【レポートの概要(一部)】
1 Table of Contents
1 Table of Contents 9
1.1 List of Tables 14
1.2 List of Figures 17
2 Introduction 18
2.1 Catalyst 18
2.2 Related Reports 19
2.3 Upcoming Related Reports 19
3 Disease Overview 20
3.1 Etiology and Pathophysiology 20
3.1.1 Etiology 20
3.1.2 Pathophysiology 21
3.2 Symptoms 22
3.2.1 Ankylosing Spondylitis 22
3.2.2 Non-radiographic Axial Spondyloarthritis 24
4 Epidemiology 25
4.1 Risk Factors and Comorbidities 27
4.2 Global Trends 28
4.2.1 US 31
4.2.2 5EU 31
4.2.3 Japan 32
4.3 Forecast Methodology 32
4.3.1 Sources Used for Diagnosed Prevalence of AS 35
4.3.2 Sources Used for Diagnosed Prevalence of Nr-axSpA 38
4.3.3 Sources Used for the Prevalence of HLA-B27 Seropositivity in Diagnosed AS 39
4.3.4 Sources Not Used 40
4.3.5 Forecast Assumptions and Methods, Diagnosed Prevalent Cases of AS — Base Scenario 41
4.3.6 Forecast Assumptions and Methods, Diagnosed Prevalent Cases of Nr-axSpA — Base Scenario 43
4.3.7 Forecast Assumptions and Methods, HLA-B27 Seropositivity in Diagnosed AS 45
4.3.8 Forecast Assumptions and Methods, Diagnosed Prevalent Cases of AS — Alternative Scenario 45
4.3.9 Forecast Assumptions and Methods, Diagnosed Prevalent Cases of Nr-axSpA — Alternative Scenario 46
4.4 Epidemiological Forecast for AS (2014-2024) — Base Scenario 46
4.4.1 Diagnosed Prevalent Cases of AS 46
4.4.2 Age-Specific Diagnosed Prevalent Cases of Ankylosing Spondylitis 48
4.4.3 Sex-Specific Diagnosed Prevalent Cases of AS 49
4.4.4 Age-Standardized Diagnosed Prevalence of AS 51
4.4.5 Diagnosed Prevalent Cases of Nr-axSpA 52
4.4.6 Prevalent Cases of HLA-B27 Seropositivity in Diagnosed AS Cases 54
4.5 Epidemiological Forecast for AS (2014-2024) — Alternative Scenario 57
4.5.1 Diagnosed Prevalent Cases of AS 57
4.5.2 Diagnosed Prevalent Cases of Nr-axSpA 58
4.6 Discussion 60
4.6.1 Epidemiological Forecast Insight 60
4.6.2 Limitations of the Analysis 61
4.6.3 Strengths of the Analysis 61
5 Current Treatment Options 63
5.1 Overview 63
5.2 Product Profiles — Major Brands 65
5.2.1 Enbrel (etanercept) 65
5.2.2 Humira (adalimumab) 69
5.2.3 Remicade (infliximab) 73
5.2.4 Simponi (golimumab) 77
5.2.5 Cimzia (certolizumab pegol) 82
5.2.6 NSAIDs 86
5.2.7 Biosimilars 92
5.2.8 Other Therapies 99
6 Unmet Needs Assessment and Oppportunity Analysis 100
6.1 Overview 100
6.2 Lack of Awareness 101
6.2.1 Unmet Need 101
6.2.2 Gap Analysis 103
6.2.3 Opportunity 105
6.3 Standardization of Diagnosis and Early Treatment 105
6.3.1 Unmet Need 105
6.3.2 Gap Analysis 107
6.3.3 Opportunity 108
6.4 Drugs With Novel MOAs 109
6.4.1 Unmet Need 109
6.4.2 Gap Analysis 110
6.4.3 Opportunity 111
6.5 Recognition of Nr-axSpA 111
6.5.1 Unmet Need 111
6.5.2 Gap Analysis 113
6.5.3 Opportunity 114
7 R&D Strategies 115
7.1 Overview 115
7.1.1 Life-Cycle Management Strategies: Expansion from Key Autoimmune Indications 115
7.1.2 Life-Cycle Management Strategies: Expansion into Nr-axSpA 117
7.1.3 Development of New Formulations and Drug Delivery Methods 118
7.2 Clinical Trial Design 119
7.2.1 Ankylosing Spondylitis 119
7.2.2 Non-radiographic Axial Spondyloarthritis 123
7.2.3 Future Clinical Trials 124
8 Pipeline Assessment 126
8.1 Overview 126
8.2 Promising Drugs in Clinical Development 126
8.2.1 Cosentyx (Secukinumab) 126
8.2.2 Stelara (ustekinumab) 134
8.2.3 Otezla (apremilast) 140
8.3 Additional Drugs in Development for AS 145
9 Pipeline Valuation Analysis 149
9.1 Clinical Benchmarking of Key Pipeline Drugs 149
9.2 Commercial Benchmark of Key Pipeline Drugs 150
9.3 Competitive Assessment 152
9.4 Top Line Ten Year Forecast 154
9.4.1 US 160
9.4.2 5EU 162
9.4.3 Japan 163
10 Appendix 164
10.1 Abbreviations 164
10.2 Bibliography 168
10.3 Methodology 185
10.4 Forecasting Methodology 185
10.4.1 Diagnosed Patients 185
10.4.2 Percent Drug-Treated Patients 186
10.4.3 Drugs Included in Each Therapeutic Class 186
10.4.4 Launch and Patent Expiry Dates 187
10.4.5 General Pricing Assumptions 187
10.4.6 Individual Drug Assumptions 189
10.4.7 Generic Erosion 193
10.4.8 Pricing of Pipeline agents 193
10.5 Physicians and Specialists Included in this Study 194
10.6 Primary Research – Prescriber Survey 195
10.7 About the Authors 196
10.7.1 Author 196
10.7.2 Therapy Area Director 196
10.7.3 Epidemiologist 197
10.7.4 Global Head of Healthcare 197
10.8 About GlobalData 198
10.9 Disclaimer 198
【レポート販売概要】
■ タイトル:脊椎関節炎治療薬の世界市場機会分析■ 英文:OpportunityAnalyzer: Axial Spondyloarthritis - Opportunity Analysis and Forecast to 2024 - Event-Driven Update
■ 発行日:2015年7月13日
■ 調査会社:GlobalData
■ 商品コード:GDHC012EPOA
■ 調査対象地域:グローバル
- ぶどう膜炎(Uveitis):治療薬開発パイプライン動向(2015年上半期版)Uveitis - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Uveitis - Pipeline Review, H1 2015’, provides an overview of the Uveitis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Uveitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administratio …
- ヘルスケアCRMの世界市場分析:用途別(コミュニティー・アウトリーチ、ケース・コーディネーション・マネジメント、リレーションシップ・マネジメント)、技術別(クラウドベース、予測、協力的)、セグメント予測、2014-2025The global healthcare CRM market is expected to reach USD 17.4 billion by 2025, according to a new study by Grand View Research Inc. Rising demand for workflow automation and single platform for tracking medical information provides coordination of patient care, service and timely delivery which is expected to drive the industry growth. The healthcare payers, providers and life science companies a …
- 地球温暖化と保険業界:Global Warming & the Insurance IndustryGlobal warming refers to the increase in the average temperature of the Earth's near-surface air and oceans in recent decades and its projected continuation. Though it is difficult to connect specific weather events to global warming, an increase in global temperatures may in turn cause other changes, including glacial retreat and worldwide sea level rise. Changes in the amount and pattern of prec …
- 世界の雲母市場:市場規模、動向、メーカー動向Scope The report presents a thorough study of miсa, covering both global and regional markets It aims to give a proper picture of the market, as well as its trends, perspectives and opportunities Comprehensive data showing miсa production, consumption, trade statistics and prices are provided (both nationwide and worldwide) Each country’s market overview covers the following: miсa production in th …
- ゴルフアパレルの世界市場2017-2021:ゴルフウェア、ゴルフシューズAbout Golf Apparel The global golf apparel market has been witnessing growth over the last few years and is shaping up to become one of the top competitive markets. With globalization, ample growth opportunities are being created in the market. The importance of health and wellness among people has increased. Rapid changes in lifestyles have had a positive impact on the demand for athleisure cloth …
- スモールセル、WiFi、DAS、クラウドRAN、HetNetデータ2014-2020(The Small Cells, WiFi, DAS, Cloud RAN & HetNet Datasheet: 2014~2020)Part of the “HetNet Bible: 2013 ? 2020”, this datasheet provides in-depth revenue forecasts on the small cells, carrier WiFi, Distributed Antenna Systems (DAS), cloud Radio Access Networks (RAN) and small cell backhaul. Market forecasts and historical revenue figures from 2010 till 2020 are provided for each of the following categories: Small Cells Carrier WiFi Small Cell Backhaul Small Cells as a …
- Talisman Energy Inc.:石油・ガスの開発・生産動向及びコスト分析- Q2, 2013Talisman Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary Talisman Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source f …
- 世界のインメモリーコンピューティング市場:Global In-memory Computing Market 2014-2018TechNavio's analysts forecast the Global In-Memory Computing market to grow at a CAGR of 43.86 percent over the period 2014-2018. One of the key factors contributing to this market growth is the rapid data explosion in networks. The Global In-Memory Computing market has also been witnessing the rise in demand from SMEs. However, the data security issues and lack of confidence could pose a challeng …
- 世界の拡張現実市場:Global Augmented Reality Market 2014-2018TechNavio's analysts forecast the Global Augmented Reality market to grow at a CAGR of 132.2 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing number of applications. The Global Augmented Reality market has also been witnessing the rapid development of network infrastructure. However, the high cost of augmented reality devices could pose …
- 世界のスマートウィンドウ(Smart Window)市場動向(2014-2021)NanoMarkets has now been tracking the smart windows for five years and has produced detailed studies of this market and related businesses including the smart windows materials markets and smart auto glass. Our understanding of new high-tech glass markets has been further enhanced by our studies of BIPV glass, self-healing and self-cleaning glass and various segments of the display glass sector. A …
- Faroe Petroleum plc:石油・ガスの開発・生産動向及びコスト分析- 2012Faroe Petroleum plc Oil & Gas Exploration and Production Operations and Cost Analysis - 2012 Summary Faroe Petroleum plc Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key …
- 世界のリテールバンキングIT市場動向(2012-2016)TechNavio's analysts forecast the Global Retail Banking IT market to grow at a CAGR of 4.1 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing need for customer satisfaction. The Global Retail Banking IT market has also been witnessing increasing need to comply with banking regulatory policies. However, meeting the diverse demands of custo …
- 世界のバイオインフォマティクス(生命情報学)市場展望:データ分析/ソフトウェア、ツール及びデータサービス、ITインフラThe Bioinformatics market has risen exponentially in recent years into an important segment of the biotechnology industry. The increasing application of genomics, proteomics, cheminformatics, transcriptomics, metabolomics, molecular phylogenetics etc. in biotech and pharmaceutical research & development has created a huge commercial market for bioinformatics worldwide. Over the past decade, countr …
- フルオロエラストマーの世界市場予測(~2022年):フルオロカーボン、フルオロシリコーン、パーフロロエラストマーThe fluoroelastomer market is projected to reach USD 1.64 Billion by 2022, at a CAGR of 6.2%, growing from USD 1.21 Billion in 2017. Fluoroelastomers are used in the manufacture of O-rings, seals & gaskets, and hoses. These sealing products are used across various end-use industries such as automotive, aerospace, oil & gas, energy & power, semiconductors, chemical processing, pharmaceutical, food …
- スチレン・ブタジエンゴム(SBR)の世界市場:用途及び地域別分析The report covers the important styrene butadiene rubber global markets. It further divides the market on the basis of applications and geography. The market data for these types has been provided with respect to volume (thousand tons) and value ($million). The market value of styrene butadiene rubber was estimated to be $13,245 million in 2013 and is projected to grow at a CAGR of about 3.3% from …